Advances in microbial extracellular vesicles: synthetic biology platforms and medical applications
Extracellular Vesicles and Circulating Nucleic Acids · 22.06.2026 · 7 (2) · 945-72
DOI: 10.20517/evcna.2025.103 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Extracellular Vesicles and Circulating Nucleic Acids, online erschienen am 22.06.2026. Verfasst von Zi-Yue-Er Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu University, Chengdu 610081, Sichuan, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Extracellular vesicles (EVs), typically ranging from 20 to 400 nanometers in diameter, are membrane-bound structures released into the extracellular environment by bacteria via specific secretion mechanisms. Consequently, these vesicles play a crucial role in bacterial physiological regulation and communication with hosts. Compared with EVs derived from plants and animals, Microbial extracellular vesicles (MEVs) offer distinct advantages, including lower production costs, higher yields, and greater abundance. This review outlines the biogenesis and release mechanisms of MEVs, and highlights how synthetic biology tools and platforms can be leveraged to engineer these vesicles, such as enhancing their production, modifying their cargo, and tailoring their surface properties. Furthermore, this article examines the promising biomedical applications of engineered MEVs, including targeted drug delivery, immune and inflammatory modulation, the discovery of disease biomarkers and therapeutic development. However, clinical translation of MEVs faces considerable challenges, primarily due to the lack of standardized, universally applicable isolation and purification protocols. This review therefore summarises contemporary extraction methods, functional characteristics and applications of MEVs alongside examples of recent MEV modifications. Ultimately, this work aims to bridge existing knowledge gaps and facilitate the development of MEV-based therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu University, Chengdu 610081, Sichuan, China.
- These authors contributed equally to this work.
- Tianjin Key Laboratory of Conservation and Utilization of Animal Diversity, College of Life Sciences, Tianjin Normal University, Tianjin 300387, China.
- Antibiotic Innovation and Resistance Control Key Laboratory of Sichuan Province, Chengdu University, Chengdu 610081, Sichuan, China.
- The Affiliated Hospital of Southwest Medical University; National Key clinical Construction Specialty, Luzhou 646000, Sichuan, China.
Zitieren
APA
Tang, Z. Y., Yang, X. L., Zhou, Y. W., Zou, H., Li, Y., Wu, H., & Wei, D. X. (2026). Advances in microbial extracellular vesicles: synthetic biology platforms and medical applications. Extracellular Vesicles and Circulating Nucleic Acids, 7(2), 945-72. https://doi.org/10.20517/evcna.2025.103
Vancouver
Tang ZY, Yang XL, Zhou YW, Zou H, Li Y, Wu H, et al. Advances in microbial extracellular vesicles: synthetic biology platforms and medical applications. Extracellular Vesicles and Circulating Nucleic Acids. 2026;7(2):945-72. doi:10.20517/evcna.2025.103
BibTeX
@article{Tang2026,
author = {Tang, Zi-Yue-Er and Yang, Xin-Lu and Zhou, Yan-Wen and Zou, Hang and Li, Ying and Wu, Hong and Wei, Dai-Xu},
title = {Advances in microbial extracellular vesicles: synthetic biology platforms and medical applications},
journal = {Extracellular Vesicles and Circulating Nucleic Acids},
year = {2026},
volume = {7},
number = {2},
pages = {945--72},
doi = {10.20517/evcna.2025.103}
}
EUVIMED